XML 62 R153.htm IDEA: XBRL DOCUMENT v3.20.1
Non-Controlling Interests - Summary of Financial Information (Details)
€ in Thousands, $ in Thousands
Dec. 31, 2019
USD ($)
Dec. 31, 2019
EUR (€)
Dec. 31, 2018
EUR (€)
Dec. 31, 2017
EUR (€)
Dec. 31, 2016
EUR (€)
Disclosure of subsidiaries [line items]          
Non-current assets   € 10,180,427 € 8,993,795    
Current assets   5,362,184 3,483,251    
Total assets   15,542,611 12,477,046 € 10,920,264  
Non-current liabilities   7,330,285 6,523,121    
Current liabilities   1,366,558 1,257,321    
Total liabilities   8,696,843 7,780,442 7,286,299  
Total equity   6,845,768 4,696,604 3,633,965 € 3,727,978
Non-controlling interests          
Disclosure of subsidiaries [line items]          
Total equity   2,023,649 471,050 € 4,886 € 6,497
Non-controlling interests | Haema AG          
Disclosure of subsidiaries [line items]          
Non-current assets   244,107 199,056    
Current assets   32,576 19,527    
Total assets   276,683 218,583    
Non-current liabilities   22,226 98    
Current liabilities   28,386 (1,705)    
Total liabilities   50,612 (1,607)    
Total equity   226,071 220,190    
Non-controlling interests | Biotest US Corp          
Disclosure of subsidiaries [line items]          
Non-current assets   299,045 215,072    
Current assets   60,099 40,352    
Total assets   359,144 255,424    
Non-current liabilities   56,425 8,766    
Current liabilities   22,709 (2,223)    
Total liabilities   79,134 6,543    
Total equity   280,010 € 248,881    
Non-controlling interests | GDS Group          
Disclosure of subsidiaries [line items]          
Non-current assets $ 3,834,871 3,416,366      
Current assets 306,734 273,259      
Total assets 4,141,605 3,689,625      
Non-current liabilities 252,153 224,635      
Current liabilities 121,478 108,220      
Total liabilities 373,631 332,855      
Total equity $ 3,767,974 € 3,356,770